Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Remarks:
The study was conducted under GLP following the most up to date OECD guideline
Adequacy of study:
key study
Study period:
06 June 2017 - 13 November 2017
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Remarks:
Study was conducted in accordance with international guidelines and in accordance with GLP. All guideline validity criteria were met.

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2017
Report date:
2017

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
1997
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Fatty Acids, C14 and C16 sat., bisamides with 2-[(2-aminoethyl)amino]ethanol
Molecular formula:
C34H68N2O3
IUPAC Name:
Fatty Acids, C14 and C16 sat., bisamides with 2-[(2-aminoethyl)amino]ethanol
Constituent 2
Chemical structure
Reference substance name:
Fatty Acids, C15 and C16 sat., bisamides with 2-[(2-aminoethyl)amino]ethanol
Molecular formula:
C35H70N2O3
IUPAC Name:
Fatty Acids, C15 and C16 sat., bisamides with 2-[(2-aminoethyl)amino]ethanol
Constituent 3
Chemical structure
Reference substance name:
Fatty Acids, C16 sat., bisamides with 2-[(2-aminoethyl)amino]ethanol
Molecular formula:
C36H72N2O3
IUPAC Name:
Fatty Acids, C16 sat., bisamides with 2-[(2-aminoethyl)amino]ethanol
Constituent 4
Chemical structure
Reference substance name:
Fatty Acids, C15 and C18 sat., bisamides with 2-[(2-aminoethyl)amino]ethanol
Molecular formula:
C37H74N2O3
IUPAC Name:
Fatty Acids, C15 and C18 sat., bisamides with 2-[(2-aminoethyl)amino]ethanol
Constituent 5
Chemical structure
Reference substance name:
Fatty Acids, C16 and C18 sat., bisamides with 2-[(2-aminoethyl)amino]ethanol
Molecular formula:
C38H76N2O3
IUPAC Name:
Fatty Acids, C16 and C18 sat., bisamides with 2-[(2-aminoethyl)amino]ethanol
Constituent 6
Chemical structure
Reference substance name:
Fatty Acids, C17 and C18 sat., bisamides with 2-[(2-aminoethyl)amino]ethanol
Molecular formula:
C39H78N2O3
IUPAC Name:
Fatty Acids, C17 and C18 sat., bisamides with 2-[(2-aminoethyl)amino]ethanol
Constituent 7
Chemical structure
Reference substance name:
Fatty Acids, C18 sat., bisamides with 2-[(2-aminoethyl)amino]ethanol
Molecular formula:
C40H80N2O3
IUPAC Name:
Fatty Acids, C18 sat., bisamides with 2-[(2-aminoethyl)amino]ethanol
Constituent 8
Chemical structure
Reference substance name:
Stearic acid
EC Number:
200-313-4
EC Name:
Stearic acid
Cas Number:
57-11-4
Molecular formula:
C18H36O2
IUPAC Name:
stearic acid
Constituent 9
Chemical structure
Reference substance name:
Palmitic acid
EC Number:
200-312-9
EC Name:
Palmitic acid
Cas Number:
57-10-3
Molecular formula:
C16H32O2
IUPAC Name:
palmitic acid
Constituent 10
Chemical structure
Reference substance name:
Myristic acid
EC Number:
208-875-2
EC Name:
Myristic acid
Cas Number:
544-63-8
Molecular formula:
C14H28O2
IUPAC Name:
myristic acid
Constituent 11
Chemical structure
Reference substance name:
2-(2-aminoethylamino)ethanol
EC Number:
203-867-5
EC Name:
2-(2-aminoethylamino)ethanol
Cas Number:
111-41-1
Molecular formula:
C4H12N2O
IUPAC Name:
2-(2-aminoethylamino)ethanol
Test material form:
solid
Details on test material:
Identification: N-(2-{[C16-18 (EVEN NUMBERED) ALKANOYL]AMINO}ETHYL)-N-(2-HYDROXYETHYL)[C16-18 (EVEN NUMBERED) ALKYLAMIDE
Storage Conditions: Room temperature
Specific details on test material used for the study:
RADIOLABELLING INFORMATION (if applicable)
- Radiochemical purity: n/a
- Specific activity: n/a
- Locations of the label: n/a
- Expiration date of radiochemical substance: n/a

STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: ca. room temperature in the dark.
- Stability under test conditions: Assumed stable
- Solubility and stability of the test substance in the solvent/vehicle: Fully miscible in THF (tetrahydrofuran) and assumed stable.
- Reactivity of the test substance with the solvent/vehicle of the cell culture medium: no

TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: Dilutions prepared in tetrahydrofuran by mixing on a vortex mixer on the day of each experiment. Formulated concentrations purity correction was not required.
- Preliminary purification step (if any): No
- Final dilution of a dissolved solid, stock liquid or gel: Concentration of stock solution = 200 mg/mL.
- Final preparation of a solid: n/a

FORM AS APPLIED IN THE TEST (if different from that of starting material): n/a

OTHER SPECIFICS: No

Method

Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and E. coli WP2
Additional strain / cell type characteristics:
other: WP2uvrA
Metabolic activation:
with and without
Metabolic activation system:
S9 Mix
Test concentrations with justification for top dose:
1.5, 5, 15, 50, 150, 500, 1500 and 5000 micro g/plate in triplicate
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: Tetrahydrofuran
- Justification for choice of solvent/vehicle: the test item was insoluble in sterile distilled water, dimethyl sulphoxide, dimethyl formamide and acetonitrile at 50 mg/mL and acetone at 100 mg/mL but fully soluble in tetrahydrofuran at 200 mg/mL.
Controls
Untreated negative controls:
yes
Remarks:
untreated control
Positive controls:
yes
Positive control substance:
4-nitroquinoline-N-oxide
9-aminoacridine
N-ethyl-N-nitro-N-nitrosoguanidine
other: 2-Aminoanthracene (2AA)
Details on test system and experimental conditions:
METHOD OF APPLICATION: preincubation; in suspension (main test)
- Cell density at seeding (if applicable):

DURATION
- Preincubation period: 20 mins
- Exposure duration: 48 h
- Expression time (cells in growth medium): 48 h
- Selection time (if incubation with a selection agent): n/a
- Fixation time (start of exposure up to fixation or harvest of cells): n/a

SELECTION AGENT (mutation assays): n/a

SPINDLE INHIBITOR (cytogenetic assays): n/a

STAIN (for cytogenetic assays): n/a

NUMBER OF REPLICATIONS: 3

METHODS OF SLIDE PREPARATION AND STAINING TECHNIQUE USED: n/a

NUMBER OF CELLS EVALUATED: n/a

NUMBER OF METAPHASE SPREADS ANALYSED PER DOSE (if in vitro cytogenicity study in mammalian cells): n/a

CRITERIA FOR MICRONUCLEUS IDENTIFICATION: n/a

DETERMINATION OF CYTOTOXICITY
- Method: presence of bacterial lawn
- Any supplementary information relevant to cytotoxicity:

OTHER EXAMINATIONS:
- Determination of polyploidy:n/a
- Determination of endoreplication: n/a
- Methods, such as kinetochore antibody binding, to characterize whether micronuclei contain whole or fragmented chromosomes (if applicable): n/a
Rationale for test conditions:
The study was based on the in vitro technique described by Ames et al (1975), Maron and Ames (1983) and Mortelmans and Zeiger (2000), in which mutagenic effects are determined by exposing mutant strains of Salmonella typhimurium to various concentrations of the test item. These strains have a deleted excision repair mechanism which makes them more sensitive to various mutagens and they will not grow on media which does not contain histidine. When large numbers of these organisms are exposed to a mutagen, reverse mutation to the original histidine independent form takes place. These are readily detectable due to their ability to grow on a histidine deficient medium. Using these strains of Salmonella typhimurium revertants may be produced after exposure to a chemical mutagen, which have arisen as a result of a base-pair substitution in the genetic material (miscoding) or as a frameshift mutation in which genetic material is either added or deleted. Additionally, a mutant strain of Escherichia coli (WP2uvrA) which requires tryptophan and can be reverse mutated by base substitution to tryptophan independence (Green and Muriel (1976 and Mortelmans and Riccio, 2000) is used to complement the Salmonella strains.
Evaluation criteria:
There are several criteria for determining a positive result. Any, one, or all of the following can be used to determine the overall result of the study:
1. A dose-related increase in mutant frequency over the dose range tested (De Serres and Shelby, 1979).
2. A reproducible increase at one or more concentrations.
3. Biological relevance against in-house historical control ranges.
4. Statistical analysis of data as determined by UKEMS (Mahon et al., 1989).
5. Fold increase greater than two times the concurrent solvent control for any tester strain (especially if accompanied by an out‑of‑historical range response (Cariello and Piegorsch, 1996)).
A test item will be considered non-mutagenic (negative) in the test system if the above criteria are not met.
Statistics:
Statistical significance was confirmed by using Dunnetts Regression Analysis.

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of pH: not examined
- Effects of osmolality: not examined
- Evaporation from medium: not examined
- Water solubility: not examined
- Precipitation: none
- Definition of acceptable cells for analysis: All bacterial strains must have demonstrated the required characteristics as determined by their respective strain checks according to Ames et al (1975), Maron and Ames (1983) and Mortelmans and Zeiger (2000).
- Other confounding effects: no

RANGE-FINDING/SCREENING STUDIES: In the range-finding test (plate incorporation method) the test item did not cause any visible reduction in the growth of the bacterial background lawns of all of the tester strains, at all dose levels in the absence and presence of S9-mix. Therefore, the maximum recommended dose level of 5000 µg/plate was selected for main experiment.

CYTOKINESIS BLOCK (if used)
- Distribution of mono-, bi- and multi-nucleated cells: n/a

NUMBER OF CELLS WITH MICRONUCLEI
- Number of cells for each treated and control culture: n/a
- Indication whether binucleate or mononucleate where appropriate: n/a

HISTORICAL CONTROL DATA (with ranges, means and standard deviation and confidence interval (e.g. 95%)
- Positive historical control data: No
- Negative (solvent/vehicle) historical control data: Yes (2009 - 2010 data)

ADDITIONAL INFORMATION ON CYTOTOXICITY:
- Measurement of cytotoxicity used: presence of bacterial lawn
- Other observations when applicable: no

Any other information on results incl. tables

Table 1:        Test Results; Experiment 1 – With and Without Metabolic Activation (Plate Incorporation)

Concentration (µg/plate)

 

Number of revertants (mean) +/- SD

Base-pair substitution strains

Frameshift strains

TA100

TA1535

WP2uvrA

TA98

TA1537

S9-Mix

(-)

S9-Mix

(+)

S9-Mix

(-)

S9-Mix

(+)

S9-Mix

(-)

S9-Mix

(+)

S9-Mix

(-)

S9-Mix

(+)

S9-Mix

(-)

S9-Mix

(+)

Solvent Control

(THF)

79

81

22

18

29

35

19

20

14

12

1.5 µg

75

75

18

23

24

37

13

24

13

16

5 µg

76

87

14

20

23

31

15

23

16

14

15 µg

78

92

22

21

25

30

13

23

16

15

50 µg

91

85

19

23

34

32

19

21

17

16

150 µg

76

89

18

21

27

33

18

14

18

15

500 µg

73

94P

21P

23P

28P

36P

19P

18P

17P

14P

1500 µg

86

83P

26P

22P

25P

30P

21P

22P

15P

14P

5000 µg

66

62P

16P

20P

22P

26P

16P

19P

10P

9P

Positive controls

Name

ENNG

2AA

ENNG

2AA

ENNG

2AA

4NQO

BP

9AA

2AA

Dose Level

3 µg

1 µg

5 µg

2 µg

2 µg

10 µg

0.2 µg

5 µg

80 µg

2 µg

No. of Revertants

430

1797

313

217

742

153

170

144

397

422

ENNG - N-ethyl-N'-nitro-N-nitrosoguanidine

4NQO - 4-Nitroquinoline-1-oxide

9AA - 9-Aminoacridine

2AA - 2-Aminoanthracene

BP -  Benzo(a)pyrene

P  -  Test item precipitate

Table 2:       Test Results; Experiment 2 – Without Metabolic Activation (Pre-Incubation)

Concentration (µg/plate)

 

Number of revertants (mean) +/- SD

Base-pair substitution strains

Frameshift strains

TA100

TA1535

WP2uvrA

TA98

TA1537

S9-Mix

(-)

S9-Mix

(+)

S9-Mix

(-)

S9-Mix

(+)

S9-Mix

(-)

S9-Mix

(+)

S9-Mix

(-)

S9-Mix

(+)

S9-Mix

(-)

S9-Mix

(+)

Solvent Control

(THF)

76

72

10

17

16

24

13

25

10

9

15 µg

66

67

10

21

17

19

17

23

8

8

50 µg

66

65

10

14

14

19

15

17

8

12

150 µg

62

72

9

13

18

17

14

17

12

8

500 µg

61P

72P

10P

18P

18P

18P

15P

28P

10P

7P

1500 µg

69P

69P

9P

20P

14P

20P

14P

27P

10P

9P

5000 µg

63P

75P

11P

21P

18P

21P

12P

19P

9P

8P

Positive controls

Name

ENNG

2AA

ENNG

2AA

ENNG

2AA

4NQO

BP

9AA

2AA

Dose Level

 

3 µg

1 µg

5 µg

2 µg

2 µg

10 µg

0.2 µg

5 µg

80 µg

2 µg

No. of Revertants

623

977

1434

169

534

120

262

165

225

292

ENNG - N-ethyl-N'-nitro-N-nitrosoguanidine

4NQO - 4-Nitroquinoline-1-oxide

9AA - 9-Aminoacridine

2AA - 2-Aminoanthracene

BP -  Benzo(a)pyrene

P  -  Test item precipitate

Applicant's summary and conclusion

Conclusions:
It was concluded that the test itme was non-mutagenic under the conditions of the test.
Executive summary:

OECD 471 (2011) - In a reverse gene mutation assay in bacteria strains: TA100, TA1535, TA98 and TA1537 of S. Typhimurium and WP2uvrA of E. Coli were exposed to

N-(2-{[C16-18 (even numbered) alkanoyl]amino}ethyl)-N-(2-hydroxyethyl)[C16-18 (even numbered) alkylamide

in tetrahydrofuran at concentrations of 1.5, 5, 15, 50, 150, 500, 1500 and 5000µg/plate with and without metabolic activation in plate incorporation and pre-incubation methods test system.

N-(2-{[C16-18 (even numbered) alkanoyl]amino}ethyl)-N-(2-hydroxyethyl)[C16-18 (even numbered) alkylamide

was tested up to cytotoxic concentrations. The positive controls induced the appropriate responses in the corresponding strains. The vehicle (tetrahydrofuran) control plates gave counts of revertant colonies within the normal range.

 

There was no evidence of induced mutant colonies over background in the test item treated colonies.

 

This study is classified as acceptable.  This study satisfies the requirement for Test Guideline OECD 471 for in vitro mutagenicity (bacterial reverse gene mutation) data.